Co-Diagnostics (NASDAQ: CODX) reported Q2 EPS of ($0.31), $0.07 worse than the analyst estimate of ($0.24). Revenue for the quarter came in at $200 thousand versus the consensus estimate of $500 thousand.

For earnings history and earnings-related data on Co-Diagnostics (CODX) click here.